Baystreet Staff - Thursday, March 23, 2017 Bellicum Pharmaceuticals (BLCM) Drops on Public Offering Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) fell 5.6% to $13.57. Bellicum Pharmaceuticals reported a proposed public offering of five million shares of common stock. Share volume totaled 238,000, compared to an all-day average of 398,000